Hypersensitive C-reactive protein-atherogenic index as a novel marker for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus
The CAI could serve as a novel marker for screening high-risk populations for MASLD in T2DM.
Authors
- Xiu Li Guo
- Yan Chen (ORCID: https://orcid.org/0000-0003-1017-4007)
- Wei Wang (ORCID: https://orcid.org/0000-0002-5386-9530)
- Yan Tong (ORCID: https://orcid.org/0000-0003-0866-7144)
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-11-19
- DOI
- https://doi.org/10.3389/fendo.2025.1721278
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00